KING OF PRUSSIA, PA--(Marketwired - February 08, 2017) - Genomind, a personalized medicine company advancing mental healthcare through genetic testing, has completed an $11 million financing with its ...
CHALFONT, PA--(Marketwired - September 23, 2013) - Genomind, a personalized medicine company in neuropsychiatry, is excited to announce the launch of their new clinician portal. The new Genomind ...
Genomind, a King of Prussia-based mental health company, and NeuroFlow, a Philadelphia-based health care analytics and technology company, recently announced an agreement to partner their proprietary ...
A breakthrough in the translation of genetic mechanisms and traits that can influence a person’s behavioral predispositions, Genomind Mental Health Map provides the starting point to empower consumers ...
February 16, 2012 – Boston, MA – Genomind today announced that the Massachusetts General Hospital (MGH) Department of Psychiatry is beginning a major inpatient study examining the use of genetic ...
Genomind’s new CORE Anxiety and Depression Report is the most advanced and comprehensive depression and anxiety-focused service available in the mental health PGx market. It analyzes 15 genes that ...
“NextUp” is a weekly NextHealth PHL feature that highlights the local leaders, organizations and research shaping the Greater Philadelphia region’s life sciences ecosystem. Email qmuse@phillymag.com ...
KING OF PRUSSIA, PA--(Marketwired - January 09, 2017) - In 2016, more Americans underwent genetic testing performed by Genomind (www.genomind.com) to help guide treatment of mental illness than in any ...
KING OF PRUSSIA, Pa. and ATLANTA, Dec. 9, 2019 /PRNewswire/ -- Genomind®, the leading mental health company, and Sharecare, the digital health company that helps people manage all their health in one ...
CHALFONT, PA--(Marketwired - October 22, 2013) - Genomind, a personalized medicine company, is pleased to announce their participation at the American Academy of Child & Adolescent Psychiatry (AACAP) ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The partnership will expand access to Genomind's Genecept ...